You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

FOLIC ACID Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Folic Acid patents expire, and when can generic versions of Folic Acid launch?

Folic Acid is a drug marketed by Ben Venue, Fresenius Kabi Usa, Xgen Pharms, Amneal Pharm, Athem, Barr, Cadila Pharms Ltd, Chartwell Molecular, Contract Pharmacal, Endo Operations, Everylife, Halsey, Hikma Pharms, Impax Labs, Ivax Sub Teva Pharms, Jubilant Cadista, Lannett, Leading, Lilly, Mk Labs, Nexgen Pharma Inc, Nuvo Pharms Inc, Pharmeral, Pioneer Pharms, Purepac Pharm, Qingdao Baheal Pharm, Sandoz, Sun Pharm Industries, Tablicaps, UDL, Usl Pharma, Valeant Pharm Intl, Vangard, Vintage Pharms, Watson Labs, and Whiteworth Town Plsn. and is included in thirty-eight NDAs.

The generic ingredient in FOLIC ACID is folic acid. There are ten drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the folic acid profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Folic Acid

A generic version of FOLIC ACID was approved as folic acid by WATSON LABS on December 31st, 1969.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for FOLIC ACID?
  • What are the global sales for FOLIC ACID?
  • What is Average Wholesale Price for FOLIC ACID?
Drug patent expirations by year for FOLIC ACID
Drug Prices for FOLIC ACID

See drug prices for FOLIC ACID

Drug Sales Revenue Trends for FOLIC ACID

See drug sales revenues for FOLIC ACID

US Patents and Regulatory Information for FOLIC ACID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Valeant Pharm Intl FOLIC ACID folic acid TABLET;ORAL 080903-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Sun Pharm Industries FOLIC ACID folic acid TABLET;ORAL 040582-001 Jul 18, 2005 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Vangard FOLIC ACID folic acid TABLET;ORAL 088730-001 Mar 23, 1984 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

FOLIC ACID Market Analysis and Financial Projection Experimental

Folic Acid Market Dynamics and Financial Trajectory

Introduction to Folic Acid

Folic acid, a form of vitamin B9, is a crucial nutrient with widespread health benefits, particularly in preventing neural tube defects during pregnancy and addressing various micronutrient deficiencies. The market for folic acid is experiencing significant growth, driven by increasing health awareness, regulatory support, and technological advancements.

Global Market Size and Growth Projections

The global folic acid market is poised for substantial growth. As of 2024, the market is estimated to be worth approximately USD 627.5 million and is projected to expand at a Compound Annual Growth Rate (CAGR) of 4.8% to reach USD 1,233.2 million by 2034[1].

Key Growth Drivers

Increased Health Awareness

The growing awareness of the health benefits of folic acid is a major driver of market growth. Consumers are increasingly recognizing the importance of folic acid in preventing neural tube defects, treating folate deficiency diseases, and improving overall health. This awareness has led to a higher demand for folic acid in various segments, including nutraceuticals, pharmaceuticals, and food products[1][3].

Regulatory Support

Governments worldwide have mandated the fortification of food products with folic acid to prevent neural tube defects during pregnancy. This regulatory support has significantly boosted the demand for folic acid, particularly in the food sector. Food producers are fortifying cereals, bread, and beverages with folic acid, which not only enhances the nutrient value of these foods but also provides consumers with an easy way to meet their folic acid needs[1].

Technological Advancements

Advancements in bioavailability and drug delivery systems are further driving the market growth. Improved formulations and delivery methods have made folic acid more effective and easier to consume, which has increased its adoption in both pharmaceutical and nutraceutical applications[1].

Market Segments

Food Segment

The food segment is one of the largest consumers of folic acid, with a projected value share of 24.7% by 2034. The increasing use of fortified foods, such as cereals and bread, is driving this segment. Consumers are appreciating the benefits of consuming folic acid through these fortified foods, especially during pregnancy and to enhance specific health conditions[1].

Pharmaceutical Segment

The pharmaceutical segment is another significant market for folic acid. The rising prevalence of anemia and other folate deficiency diseases has increased the demand for folic acid supplements and medications. Obstetricians often recommend prenatal vitamins that include folic acid to support healthy fetal development and reduce birth defects[3][4].

Nutraceutical Segment

The nutraceutical segment is also experiencing growth due to the increasing demand for dietary supplements that contain folic acid. These supplements are aimed at improving overall health and addressing specific health conditions, further propelling the demand for folic acid[1][3].

Regional Market Dynamics

North America

North America is anticipated to dominate the folic acid market, driven by substantial investments in product innovation and research and development. The region's advanced manufacturing base and technological expertise are key factors contributing to its leadership in the market[4].

Europe

Europe also shows significant demand for folic acid, influenced by stringent regulations and favorable amendments by the European Union. The region's regulatory environment supports the use of folic acid in various applications, contributing to the market's growth[4].

Competitive Landscape

The folic acid market is highly competitive, with major players such as DSM NV, BASF SE, and Parchem Fine & Specialty Chemicals leading the industry. These companies are driving innovation through recent product launches, such as Merck's Arcofolin™ L-Methylfolate, which cater to both nutritional and pharmaceutical applications[4].

Impact of COVID-19

The COVID-19 pandemic has positively impacted the folic acid market by increasing awareness of preventative health measures. The pandemic has led to an inclination towards regular intake of supplements and fortified food products, thereby propelling the overall demand for folic acid[4].

Financial Trajectory

Historical Growth

From 2019 to 2023, the global folic acid market grew at a CAGR of 3.7%. This growth was driven by the increasing recognition of folic acid's health benefits and regulatory support for food fortification[1].

Future Projections

For the period from 2024 to 2034, the market is projected to grow at a CAGR of 4.8%. This growth will be driven by continued awareness of health benefits, advancements in technology, and the expanding use of folic acid in various segments[1].

Semi-Annual Growth Rates

The market's growth is expected to vary slightly over semi-annual periods. For the decade from 2023 to 2033, the CAGR is predicted to be 5.4% in the first half and 4.6% in the second half. For the subsequent period from 2024 to 2034, the CAGR is projected to be 4.4% in the first half and 5.0% in the second half[1].

Key Takeaways

  • The global folic acid market is expected to grow significantly, reaching USD 1,233.2 million by 2034.
  • Increased health awareness, regulatory support, and technological advancements are key drivers of market growth.
  • The food, pharmaceutical, and nutraceutical segments are major consumers of folic acid.
  • North America and Europe are leading regions in the market, driven by innovation and regulatory support.
  • The COVID-19 pandemic has positively impacted the market by increasing the demand for preventative health measures.

FAQs

What is the current size of the global folic acid market?

The global folic acid market is estimated to be worth approximately USD 627.5 million in 2024[1].

What is the projected CAGR for the folic acid market from 2024 to 2034?

The market is projected to grow at a CAGR of 4.8% from 2024 to 2034[1].

Which segments are driving the growth of the folic acid market?

The food, pharmaceutical, and nutraceutical segments are major drivers of the market growth[1][3].

How has the COVID-19 pandemic impacted the folic acid market?

The COVID-19 pandemic has positively impacted the market by increasing awareness of preventative health measures and the demand for supplements and fortified food products[4].

Which regions are expected to dominate the folic acid market?

North America and Europe are anticipated to dominate the market, driven by innovation, regulatory support, and advanced manufacturing capabilities[4].

Sources

  1. Future Market Insights: Folic Acid Market Size, Share, Sales & Growth to 2034
  2. Global Nutrition Report: Financing nutrition - Global Nutrition Report
  3. Adroit Market Research: Folic Acid Market Trends and Growth Drivers
  4. Mordor Intelligence: Folic Acid Market Size (2024 - 2029)
  5. News Channel Nebraska: Folic Acid Market Growth Insights 2024: Competitive Strategies, Future Trends, and Global Share Forecast to 2032

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.